Gilda Cennamo
Federico II University
11
11
11
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Daniela Montorio
Federico II University
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Emily Y Chew, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Toshimitsu Tokimoto
Astrazeneca KK
Shared therapeutic areas:
Mohamed mamdouh Elsayed, MD
Lecturer
Shared therapeutic areas:
Ken Nedd, M.D.
GAAD Medical Research Institute Inc.
Shared therapeutic areas:
Roman Hovorka, PhD
University of Cambridge
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection
Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg
Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery
Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months
OCTA and Retinal Angiomatous Proliferation
OCTA and Polypoidal Choroidal Vasculopathy
Long-term Follow up for Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery.
Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery
Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab
Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab
All 11 trials loaded